Vericel (VCEL) Return on Sales (2016 - 2025)
Historic Return on Sales for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to 0.08%.
- Vericel's Return on Sales rose 900.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.04% for FY2024, which is 600.0% up from last year.
- As of Q3 2025, Vericel's Return on Sales stood at 0.08%, which was up 900.0% from 0.01% recorded in Q2 2025.
- Over the past 5 years, Vericel's Return on Sales peaked at 0.26% during Q4 2024, and registered a low of 0.24% during Q2 2022.
- Moreover, its 5-year median value for Return on Sales was 0.09% (2024), whereas its average is 0.05%.
- Data for Vericel's Return on Sales shows a peak YoY increase of 3200bps (in 2021) and a maximum YoY decrease of -2600bps (in 2021) over the last 5 years.
- Over the past 5 years, Vericel's Return on Sales (Quarter) stood at 0.1% in 2021, then rose by 18bps to 0.11% in 2022, then surged by 78bps to 0.2% in 2023, then soared by 31bps to 0.26% in 2024, then crashed by -71bps to 0.08% in 2025.
- Its Return on Sales was 0.08% in Q3 2025, compared to 0.01% in Q2 2025 and 0.21% in Q1 2025.